Dr Rob van der Pluijm from MORU (Mahidol Oxford Research Unit) in Bangkok, Thailand, tells us about his work as project coordinator in mapping resistance to antimalarials Anti-malaria drug resistance is spreading throughout Southeast Asia and we need to find new treatments. Our researchers at MORU use a combination of artemisinin and two partner drugs instead of one. If confirmed safe and tolerable, triple artemisinin combination therapies might be a good option to treat multi-drug resistant malaria, as well as slow down the emergence and spread of anti-malarial resistance.
Podden och tillhörande omslagsbild på den här sidan tillhör
Oxford University. Innehållet i podden är skapat av Oxford University och inte av,
eller tillsammans med, Poddtoppen.
